Skip to content

SankoreAfrican research intelligence

Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Possible therapeutic options and management of COVID-19

2022Research Society and DevelopmentJournalOpen access

10.33448/rsd-v11i5.28002 Full text0 citations

Authors

7 authors across 5 institutions in 3 countries.

Ayobami Mathew OlajuyinFirst author
- American University of Nigeria (NG)
as printed: Olajuyin Ayobami Matthew
Olajuyin Adefunke Kafayat
Ayodeji Adegoke
- University of the Free State (ZA)
- University of Ibadan (NG)
as printed: Adegoke Ayodeji Mathias
Jamiyu A. Saliu
- Adekunle Ajasin University (NG)
as printed: Jamiyu Ayodeji Saliu
Hayatu Raji
- American University of Nigeria (NG)
as printed: Raji Muhammed Hayatu
Malachy I. Okeke
- American University of Nigeria (NG)
as printed: Okeke Ifeanyi Malachy
Zhang XiaojuSenior author

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

SARS-CoV-2 and COVID-19 Researchlevel 3 · 0.98
COVID-19 Clinical Research Studieslevel 3 · 0.98
Phagocytosis and Immune Regulationlevel 3 · 0.97

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2022 · Research Society and Development · 0 citations
https://openalex.org/W4223995900

Possible therapeutic options and management of COVID-19 · Sankore